A CANADIAN appeals court has upheld a lower court's decision denying a pharmaceutical company's motion to block publication of a health technology report that the company contends may damage its commercial interests.
In December 1997, Bristol-Myers Squibb Canada Inc sued the Canadian Coordinating Office of Health Technology Assessment (CCOHTA) to prevent the release of its summary report on cholesterol-lowering statin drugs. The company contends that the report contains "negligent misstatements" that could negatively affect the sale of its drug Pravachol (pravastatin).
Skolnick AA. Drug Firm Suit Fails to Halt Publication of Canadian Health Technology Report. JAMA. 1998;280(8):683–684. doi:10.1001/jama.280.8.683-JMN0826-2-1
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: